SIMILAR PATTERNS OF AMINO ACIDS FOR 3QXV_D_MTXD2000

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1g6v ANTIBODY HEAVY CHAIN

(Camelus
dromedarius) 		PF07686
(V-set) 		5 VAL K 802
ALA K 824
MET K 834
VAL K 877
TYR K 915
 None
 0.69A 3qxvD-1g6vK:
20.1		 3qxvD-1g6vK:
69.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1i3u ANTIBODY VHH LAMA
DOMAIN

(Lama glama) 		PF07686
(V-set) 		5 ALA A  24
ARG A  77
VAL A  84
ALA A 103
TYR A 118
 None
None
None
None
CGN  A   1 ( 4.0A)
 0.84A 3qxvD-1i3uA:
20.8		 3qxvD-1i3uA:
59.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1kxt IMMUNOGLOBULIN VHH
FRAGMENT

(Camelus
dromedarius) 		PF07686
(V-set) 		5 VAL B   2
ALA B  24
MET B  34
ALA B  94
TYR B 102
 None
 0.98A 3qxvD-1kxtB:
19.2		 3qxvD-1kxtB:
68.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1pz5 HEAVY CHAIN OF FAB
(SYA/J6)

(Mus musculus) 		PF07654
(C1-set)
PF07686
(V-set) 		5 VAL B   2
ALA B  24
MET B  34
ARG B  71
VAL B  78
 None
 0.79A 3qxvD-1pz5B:
19.9		 3qxvD-1pz5B:
51.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1t3q QUINOLINE
2-OXIDOREDUCTASE
LARGE SUBUNIT

(Pseudomonas
putida) 		PF01315
(Ald_Xan_dh_C)
PF02738
(Ald_Xan_dh_C2) 		5 ALA B 314
ARG B 416
SER B 354
ARG B 188
VAL B 186
 None
 0.93A 3qxvD-1t3qB:
undetectable		 3qxvD-1t3qB:
10.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1t66 IMMUNOGLOBULIN HEAVY
CHAIN

(Mus musculus) 		no annotation 5 ALA H  24
MET H  34
ARG H  74
VAL H  81
TYR H 107
 None
 0.79A 3qxvD-1t66H:
19.3		 3qxvD-1t66H:
31.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1t66 IMMUNOGLOBULIN HEAVY
CHAIN

(Mus musculus) 		no annotation 5 VAL H   2
MET H  34
ARG H  74
VAL H  81
TYR H 107
 None
 0.76A 3qxvD-1t66H:
19.3		 3qxvD-1t66H:
31.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2x6m HEAVY CHAIN VARIABLE
DOMAIN FROM
DROMEDARY

(Camelus
dromedarius) 		PF07686
(V-set) 		5 ALA A  24
MET A  34
VAL A  80
ALA A  99
TYR A 115
 None
 0.66A 3qxvD-2x6mA:
21.1		 3qxvD-2x6mA:
70.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2xa3 LLAMA HEAVY CHAIN
ANTIBODY D7

(Lama glama) 		PF07686
(V-set) 		5 SER A  29
MET A  34
VAL A  78
ALA A  94
TYR A 102
 SO4  A1114 (-2.7A)
None
None
None
None
 0.68A 3qxvD-2xa3A:
20.8		 3qxvD-2xa3A:
69.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3g9a MINIMIZER

(Camelus
dromedarius) 		PF07686
(V-set) 		7 VAL B   2
ALA B  24
MET B  34
ARG B  71
VAL B  78
ALA B  94
TYR B 102
 None
 0.83A 3qxvD-3g9aB:
19.5		 3qxvD-3g9aB:
64.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3if1 IMMUNOGLOBULIN HEAVY
CHAIN (IGG2A)

(Mus musculus) 		PF07654
(C1-set)
PF07686
(V-set) 		5 VAL B   2
ALA B  24
MET B  34
ARG B  71
TYR B 102
 None
 0.70A 3qxvD-3if1B:
19.5		 3qxvD-3if1B:
32.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3k7u ANTIBODY

(Lama glama) 		PF07686
(V-set) 		5 MET A  34
ARG A  72
VAL A  79
ALA A  98
TYR A 111
 None
 0.39A 3qxvD-3k7uA:
21.9		 3qxvD-3k7uA:
73.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ln9 IMMUNOGLOBULIN HEAVY
CHAIN ANTIBODY
VARIABLE DOMAIN B10

(Camelidae) 		PF07686
(V-set) 		5 ALA A  24
ARG A  72
VAL A  79
ALA A  98
TYR A 113
 None
None
None
None
GOL  A 137 (-4.8A)
 0.77A 3qxvD-3ln9A:
19.2		 3qxvD-3ln9A:
67.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3qxu ANTI-METHOTREXATE
CDR1-3 GRAFT

(Lama glama) 		PF07686
(V-set) 		6 SER A  30
TRP A  34
MET A  36
VAL A  81
ALA A 100
TYR A 120
 None
 1.48A 3qxvD-3qxuA:
24.0		 3qxvD-3qxuA:
96.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3qxu ANTI-METHOTREXATE
CDR1-3 GRAFT

(Lama glama) 		PF07686
(V-set) 		7 SER A  31
TRP A  34
MET A  36
ARG A  74
VAL A  81
ALA A 100
TYR A 120
 None
 1.40A 3qxvD-3qxuA:
24.0		 3qxvD-3qxuA:
96.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3qxu ANTI-METHOTREXATE
CDR1-3 GRAFT

(Lama glama) 		PF07686
(V-set) 		7 VAL A   4
ALA A  26
SER A  30
MET A  36
VAL A  81
ALA A 100
TYR A 120
 None
 0.90A 3qxvD-3qxuA:
24.0		 3qxvD-3qxuA:
96.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3qxu ANTI-METHOTREXATE
CDR1-3 GRAFT

(Lama glama) 		PF07686
(V-set) 		8 VAL A   4
ALA A  26
SER A  31
MET A  36
ARG A  74
VAL A  81
ALA A 100
TYR A 120
 None
 0.88A 3qxvD-3qxuA:
24.0		 3qxvD-3qxuA:
96.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3qyc VH DOMAIN OF IGG
MOLECULE

(Homo sapiens) 		PF07686
(V-set) 		5 VAL A   4
ALA A  26
MET A  36
ARG A  74
VAL A  81
 None
 0.69A 3qxvD-3qycA:
19.8		 3qxvD-3qycA:
61.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3r0m LLAMA VHH A12

(Lama glama) 		PF07686
(V-set) 		5 ALA A  24
SER A  29
MET A  34
VAL A  78
ALA A  94
 None
SO4  A 131 (-2.7A)
None
None
None
 0.94A 3qxvD-3r0mA:
21.2		 3qxvD-3r0mA:
70.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3stb SINGLE DOMAIN
ANTIBODY VHH

(Lama glama) 		PF07686
(V-set) 		5 ALA A  26
MET A  36
ARG A  73
VAL A  80
ALA A  99
 None
 0.65A 3qxvD-3stbA:
22.0		 3qxvD-3stbA:
70.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3tpk IMMUNOGLOBULIN HEAVY
CHAIN ANTIBODY
VARIABLE DOMAIN KW1

(Camelidae) 		PF07686
(V-set) 		5 VAL A   2
ALA A  24
VAL A  79
ALA A  98
TYR A 110
 None
BEN  A 133 (-3.6A)
BEN  A 133 (-4.6A)
BEN  A 133 ( 4.2A)
None
 0.92A 3qxvD-3tpkA:
20.3		 3qxvD-3tpkA:
64.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4aq1 NBKB6

(Lama glama) 		PF07686
(V-set) 		5 MET B  34
ARG B  72
VAL B  79
ALA B  98
TYR B 113
 None
 0.97A 3qxvD-4aq1B:
21.8		 3qxvD-4aq1B:
74.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4b41 ANTIBODY G7

(Lama glama) 		PF07686
(V-set) 		5 VAL A   2
ALA A  24
MET A  34
VAL A  78
ALA A  97
 None
 0.90A 3qxvD-4b41A:
18.6		 3qxvD-4b41A:
72.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4dka SINGLE DOMAIN
ANTIBODY VHH

(Lama glama) 		PF07686
(V-set) 		7 VAL A   2
ALA A  24
MET A  34
ARG A  72
VAL A  79
ALA A  98
TYR A 116
 None
 0.81A 3qxvD-4dkaA:
22.0		 3qxvD-4dkaA:
73.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4eig CA1698 CAMEL
ANTIBODY FRAGMENT

(Lama glama) 		PF07686
(V-set) 		6 ALA B  24
MET B  34
ARG B  71
VAL B  78
ALA B  97
TYR B 106
 None
 0.72A 3qxvD-4eigB:
20.2		 3qxvD-4eigB:
66.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4fhb NB179

(Lama glama) 		PF07686
(V-set) 		5 MET D  34
ARG D  72
VAL D  79
ALA D  98
TYR D 118
 None
 0.60A 3qxvD-4fhbD:
21.2		 3qxvD-4fhbD:
71.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4gft NANOBODY

(Lama glama) 		PF07686
(V-set) 		5 MET B  36
ARG B  74
VAL B  81
ALA B 100
TYR B 115
 None
None
None
None
PCA  B   2 ( 3.9A)
 0.38A 3qxvD-4gftB:
22.0		 3qxvD-4gftB:
66.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4hem ANTI-BASEPLATE
TP901-1 LLAMA VHH 02

(Lama glama) 		PF07686
(V-set) 		6 ALA E  24
MET E  34
ARG E  72
VAL E  79
ALA E  98
TYR E 112
 None
 0.64A 3qxvD-4hemE:
22.6		 3qxvD-4hemE:
73.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4hlz FAB C179 HEAVY CHAIN

(Mus musculus) 		PF07654
(C1-set)
PF07686
(V-set) 		5 VAL G   2
MET G  34
ARG G  71
VAL G  78
TYR G 102
 None
 0.78A 3qxvD-4hlzG:
19.0		 3qxvD-4hlzG:
53.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4hxa 13D9 FAB HEAVY CHAIN

(Mus musculus) 		PF07654
(C1-set)
PF07686
(V-set) 		5 VAL H   2
MET H  34
ARG H  71
VAL H  78
TYR H 102
 None
 0.90A 3qxvD-4hxaH:
20.6		 3qxvD-4hxaH:
53.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4krm NANOBODY/VHH DOMAIN
7D12

(Lama glama) 		PF07686
(V-set) 		6 ALA B  24
MET B  34
ARG B  72
VAL B  79
ALA B  98
TYR B 113
 None
 0.71A 3qxvD-4krmB:
23.3		 3qxvD-4krmB:
70.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4krm NANOBODY/VHH DOMAIN
7D12

(Lama glama) 		PF07686
(V-set) 		5 SER B  29
MET B  34
VAL B  79
ALA B  98
TYR B 113
 None
 0.98A 3qxvD-4krmB:
23.3		 3qxvD-4krmB:
70.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4lde CAMELID ANTIBODY
FRAGMENT

(Lama glama) 		PF07686
(V-set) 		5 VAL B   2
ALA B  24
ARG B  71
VAL B  78
TYR B 109
 None
 0.91A 3qxvD-4ldeB:
19.3		 3qxvD-4ldeB:
68.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4lde CAMELID ANTIBODY
FRAGMENT

(Lama glama) 		PF07686
(V-set) 		5 VAL B   2
MET B  34
ARG B  71
VAL B  78
TYR B 109
 None
 0.77A 3qxvD-4ldeB:
19.3		 3qxvD-4ldeB:
68.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4lhq CAMELID NANOBODY

(Vicugna pacos) 		PF07686
(V-set) 		5 ALA B  24
SER B  28
MET B  34
ARG B  72
VAL B  79
 None
 0.83A 3qxvD-4lhqB:
21.5		 3qxvD-4lhqB:
63.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4mqt NANOBODY 9-8

(Lama glama) 		PF07686
(V-set) 		5 VAL B   2
ALA B  24
VAL B  82
ALA B 101
TYR B 110
 None
 0.81A 3qxvD-4mqtB:
19.2		 3qxvD-4mqtB:
64.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4n1h CAMELID HEAVY-CHAIN
ANTIBODY VARIABLE
FRAGMENT CAB-F11N

(Lama glama) 		PF07686
(V-set) 		5 ALA B  24
MET B  34
ARG B  72
VAL B  79
ALA B  98
 None
 0.81A 3qxvD-4n1hB:
21.3		 3qxvD-4n1hB:
68.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4nc1 A20.1 VHH

(Lama glama) 		PF07686
(V-set) 		7 VAL C   9
ALA C  31
MET C  41
ARG C  79
VAL C  86
ALA C 105
TYR C 119
 None
 0.90A 3qxvD-4nc1C:
22.0		 3qxvD-4nc1C:
70.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4nc2 B39 VHH

(Lama glama) 		PF07686
(V-set) 		5 ALA B  24
MET B  34
ARG B  71
ALA B  97
TYR B 111
 None
 0.75A 3qxvD-4nc2B:
22.8		 3qxvD-4nc2B:
70.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4nc2 B39 VHH

(Lama glama) 		PF07686
(V-set) 		5 VAL B   2
MET B  34
ARG B  71
ALA B  97
TYR B 111
 None
 0.63A 3qxvD-4nc2B:
22.8		 3qxvD-4nc2B:
70.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4p2c NANOBODY 1,
ANTI-F4+ETEC
BACTERIA VHH
VARIABLE REGION

(Lama glama) 		PF07686
(V-set) 		6 VAL G   2
MET G  34
ARG G  71
VAL G  78
ALA G  97
TYR G 111
 None
 0.62A 3qxvD-4p2cG:
19.1		 3qxvD-4p2cG:
70.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4p49 ANTIBODY SCFV B8

(Gallus gallus) 		PF07686
(V-set) 		5 VAL A 122
ALA A 144
MET A 154
ARG A 193
VAL A 200
 None
 0.91A 3qxvD-4p49A:
21.7		 3qxvD-4p49A:
51.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4pb0 AB53 HEAVY CHAIN

(Mus musculus) 		PF07654
(C1-set)
PF07686
(V-set) 		5 VAL H   2
ALA H  24
MET H  34
ARG H  71
VAL H  78
 CL  H 303 (-4.4A)
None
None
None
None
 0.93A 3qxvD-4pb0H:
18.7		 3qxvD-4pb0H:
32.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4qlr LLAMA NANOBODY N02
VH DOMAIN

(Lama glama) 		PF07686
(V-set) 		5 ALA A  24
ARG A  72
VAL A  79
ALA A  98
TYR A 113
 None
 0.76A 3qxvD-4qlrA:
22.4		 3qxvD-4qlrA:
69.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4qo1 NB139 NANOBODY
AGAINST THE
DNA-BINDING DOMAIN
OF P53

(Lama glama) 		PF07686
(V-set) 		6 ALA A  25
MET A  35
ARG A  73
VAL A  80
ALA A  99
TYR A 113
 None
 0.57A 3qxvD-4qo1A:
21.2		 3qxvD-4qo1A:
62.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4tvs VHH DOMAIN BS-1

(Vicugna pacos) 		PF05609
(LAP1C) 		5 ALA a  25
ARG a  73
VAL a  80
ALA a  99
TYR a 117
 None
 0.79A 3qxvD-4tvsa:
22.1		 3qxvD-4tvsa:
72.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4w6y NANOBODY NBFEDF9

(Lama glama) 		PF07686
(V-set) 		6 VAL B   2
ALA B  24
MET B  34
VAL B  79
ALA B  98
TYR B 118
 None
 0.92A 3qxvD-4w6yB:
21.0		 3qxvD-4w6yB:
69.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4weu ANTI-F4+ETEC
BACTERIA VHH
VARIABLE REGION

(Lama glama) 		PF07686
(V-set) 		6 VAL D 802
ALA D 824
MET D 834
ARG D 872
ALA D 898
TYR D 910
 None
 0.68A 3qxvD-4weuD:
22.3		 3qxvD-4weuD:
72.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4x8j 12F4 FAB HEAVY CHAIN

(Mus musculus) 		no annotation 5 VAL H   2
MET H  34
ARG H  74
VAL H  81
TYR H 104
 None
None
None
None
2PE  H 302 ( 4.6A)
 0.67A 3qxvD-4x8jH:
15.5		 3qxvD-4x8jH:
33.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xt1 NANOBODY 7

(Vicugna pacos) 		PF07686
(V-set) 		6 VAL C   2
ALA C  24
MET C  34
VAL C  78
ALA C  97
TYR C 107
 None
 0.87A 3qxvD-4xt1C:
19.0		 3qxvD-4xt1C:
68.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5a2k IG LAMBDA-1 CHAIN V
REGION S43

(Mus musculus) 		PF07686
(V-set) 		6 VAL H   2
ALA H  24
MET H  34
ARG H  71
VAL H  78
TYR H 102
 None
 0.79A 3qxvD-5a2kH:
19.8		 3qxvD-5a2kH:
29.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5aum HEAVY CHAIN OF FAB
FRAGMENT

(Rattus) 		no annotation 5 ALA H  24
MET H  34
ARG H  71
VAL H  78
ALA H  94
 None
 0.67A 3qxvD-5aumH:
19.7		 3qxvD-5aumH:
38.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5aum HEAVY CHAIN OF FAB
FRAGMENT

(Rattus) 		no annotation 5 VAL H   2
MET H  34
ARG H  71
VAL H  78
ALA H  94
 None
 0.58A 3qxvD-5aumH:
19.7		 3qxvD-5aumH:
38.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5e1h F8(JOB10) VHH
ANTIBODY

(Vicugna pacos) 		PF07686
(V-set) 		5 VAL B   2
ALA B  24
MET B  34
ARG B  72
VAL B  79
 None
 0.83A 3qxvD-5e1hB:
20.3		 3qxvD-5e1hB:
68.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5e7f NANOBODY L06

(Camelus
dromedarius) 		PF07686
(V-set) 		5 VAL A   4
MET A  36
ARG A  73
VAL A  80
ALA A  99
 None
 0.72A 3qxvD-5e7fA:
18.4		 3qxvD-5e7fA:
66.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5fwo NANOBODY

(Lama glama) 		PF07686
(V-set) 		6 VAL A   2
ALA A  24
MET A  34
ARG A  71
VAL A  78
TYR A 102
 None
 0.87A 3qxvD-5fwoA:
21.5		 3qxvD-5fwoA:
68.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5fwo NANOBODY

(Lama glama) 		PF07686
(V-set) 		6 VAL A   2
MET A  34
ARG A  71
VAL A  78
ALA A  94
TYR A 102
 None
 0.62A 3qxvD-5fwoA:
21.5		 3qxvD-5fwoA:
68.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5gxb NANOBODY

(Vicugna pacos) 		PF07686
(V-set) 		6 VAL B   2
ALA B  24
MET B  34
VAL B  79
ALA B  98
TYR B 118
 None
 1.09A 3qxvD-5gxbB:
20.9		 3qxvD-5gxbB:
68.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5hm1 LAMA VHH ANTIBODY
2E7

(Lama glama) 		PF07686
(V-set) 		5 VAL A   2
ALA A  24
VAL A  78
ALA A  94
TYR A 102
 None
 0.69A 3qxvD-5hm1A:
18.7		 3qxvD-5hm1A:
68.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5hvf VHH-I83

(Vicugna pacos) 		PF07686
(V-set) 		6 VAL B   2
ALA B  24
ARG B  70
VAL B  77
ALA B  96
TYR B 108
 None
 0.86A 3qxvD-5hvfB:
18.5		 3qxvD-5hvfB:
69.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5hvf VHH-I83

(Vicugna pacos) 		PF07686
(V-set) 		6 VAL B   2
ALA B  24
MET B  34
VAL B  77
ALA B  96
TYR B 108
 None
 0.95A 3qxvD-5hvfB:
18.5		 3qxvD-5hvfB:
69.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5iml NANOBODY

(Camelidae) 		PF07686
(V-set) 		6 ALA B  23
MET B  33
ARG B  71
VAL B  78
ALA B  97
TYR B 113
 None
 0.75A 3qxvD-5imlB:
23.6		 3qxvD-5imlB:
75.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5j1s VHH DOMAIN BS-2

(Vicugna pacos) 		PF07686
(V-set) 		7 VAL C   3
ALA C  25
MET C  35
ARG C  72
VAL C  79
ALA C  98
TYR C 112
 None
 0.88A 3qxvD-5j1sC:
19.5		 3qxvD-5j1sC:
66.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5j56 VHH SINGLE CHAIN
ANTIBODY V1C7

(Vicugna pacos) 		PF07686
(V-set) 		6 VAL B   2
ALA B  24
ARG B  76
VAL B  83
ALA B 102
TYR B 117
 None
 0.91A 3qxvD-5j56B:
20.7		 3qxvD-5j56B:
67.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ja9 NANOBODY 6

(Lama glama) 		PF07686
(V-set) 		5 VAL A   3
ALA A  25
MET A  35
ARG A  73
ALA A  99
 None
 0.93A 3qxvD-5ja9A:
20.2		 3qxvD-5ja9A:
68.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5jqh NANOBODY60, NB60

(Lama glama) 		no annotation 5 VAL D   2
MET D  34
ARG D  71
VAL D  78
ALA D  97
 None
 0.95A 3qxvD-5jqhD:
19.2		 3qxvD-5jqhD:
70.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5kel C2G4 VARIABLE FAB
DOMAIN HEAVY CHAIN

(Homo sapiens) 		PF07686
(V-set) 		6 VAL H   2
ALA H  24
MET H  34
ARG H  71
VAL H  78
TYR H 102
 None
 0.99A 3qxvD-5kelH:
17.1		 3qxvD-5kelH:
51.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5lhq CAMELID-DERIVED
ANTIBODY FRAGMENT
NB7

(Vicugna pacos) 		PF07686
(V-set) 		6 VAL B   2
ALA B  24
ARG B  72
VAL B  79
ALA B  98
TYR B 122
 None
 0.62A 3qxvD-5lhqB:
21.6		 3qxvD-5lhqB:
64.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5lmj NANOBODY

(Lama glama) 		PF07686
(V-set) 		6 ALA A  24
MET A  34
ARG A  71
VAL A  78
ALA A  94
TYR A 102
 None
 0.95A 3qxvD-5lmjA:
20.2		 3qxvD-5lmjA:
73.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5lmj NANOBODY

(Lama glama) 		PF07686
(V-set) 		6 VAL A   2
ALA A  24
ARG A  71
VAL A  78
ALA A  94
TYR A 102
 None
 0.95A 3qxvD-5lmjA:
20.2		 3qxvD-5lmjA:
73.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5lwf CAMELID HEAVY-CHAIN
ANTIBODY VARIABLE
FRAGMENT CAB-G10S

(Lama glama) 		no annotation 6 ALA C  27
MET C  37
ARG C  75
VAL C  82
ALA C 101
TYR C 117
 None
None
None
None
None
ACT  C 202 (-4.4A)
 0.59A 3qxvD-5lwfC:
21.3		 3qxvD-5lwfC:
68.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5lwf CAMELID HEAVY-CHAIN
ANTIBODY VARIABLE
FRAGMENT CAB-G10S

(Lama glama) 		no annotation 5 VAL C   5
ARG C  75
VAL C  82
ALA C 101
TYR C 117
 None
None
None
None
ACT  C 202 (-4.4A)
 0.86A 3qxvD-5lwfC:
21.3		 3qxvD-5lwfC:
68.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5m13 SYNTHETIC NANOBODY
L2_C06 (A-MBP#2)

(synthetic
construct) 		no annotation 5 VAL B   2
ALA B  24
VAL B  79
ALA B  98
TYR B 114
 None
 0.93A 3qxvD-5m13B:
21.8		 3qxvD-5m13B:
63.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5mwn LLAMA NANOBODY
RAISED AGAINST TSSK,
NBK27

(Lama glama) 		PF07686
(V-set) 		5 VAL N   2
ALA N  24
ARG N  71
VAL N  78
ALA N  97
 None
 0.94A 3qxvD-5mwnN:
18.3		 3qxvD-5mwnN:
67.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5mwn LLAMA NANOBODY
RAISED AGAINST TSSK,
NBK27

(Lama glama) 		PF07686
(V-set) 		5 VAL N   2
ALA N  24
MET N  34
VAL N  78
ALA N  97
 None
 0.95A 3qxvD-5mwnN:
18.3		 3qxvD-5mwnN:
67.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5o02 NANOBODY (VHH)
NANO-4

(Vicugna pacos) 		PF07686
(V-set) 		5 VAL C   2
MET C  34
ARG C  72
ALA C  98
TYR C 113
 None
 0.66A 3qxvD-5o02C:
21.3		 3qxvD-5o02C:
68.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5o03 NANOBODY (VHH)
NANO-32

(Norwalk virus) 		PF07686
(V-set) 		5 ALA C  24
ARG C  72
VAL C  79
ALA C  98
TYR C 124
 None
 0.88A 3qxvD-5o03C:
20.3		 3qxvD-5o03C:
63.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5o04 NANOBODY (VHH)
NANO-26

(Vicugna pacos) 		PF07686
(V-set) 		5 VAL E   2
ALA E  24
ARG E  71
VAL E  78
TYR E 104
 None
 0.83A 3qxvD-5o04E:
18.7		 3qxvD-5o04E:
65.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5o05 NANOBODY (VHH)
NANO-42

(Vicugna pacos) 		PF07686
(V-set) 		5 VAL C   2
ALA C  24
SER C  29
VAL C  78
TYR C 109
 None
 0.90A 3qxvD-5o05C:
17.1		 3qxvD-5o05C:
67.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5o8f NANOBODY NB25

(Lama glama) 		no annotation 5 MET L  34
ARG L  72
VAL L  79
ALA L  98
TYR L 114
 None
 0.62A 3qxvD-5o8fL:
21.4		 3qxvD-5o8fL:
68.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5uk4 ANTI-VESICULAR
STOMATITIS VIRUS N
VHH

(Vicugna pacos) 		no annotation 6 VAL p   2
MET p  34
ARG p  72
VAL p  79
ALA p  98
TYR p 114
 None
 0.76A 3qxvD-5uk4p:
21.4		 3qxvD-5uk4p:
71.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ukb ANTI-VESICULAR
STOMATITIS VIRUS N
VHH

(Vicugna pacos) 		no annotation 5 ALA d  24
ARG d  72
VAL d  79
ALA d  98
TYR d 113
 None
 0.74A 3qxvD-5ukbd:
22.3		 3qxvD-5ukbd:
70.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5vgj VRC38.01 FAB HEAVY
CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 VAL H   2
ALA H  24
MET H  34
ARG H  71
VAL H  78
 None
 0.69A 3qxvD-5vgjH:
19.1		 3qxvD-5vgjH:
36.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5vxj SINGLE-DOMAIN
ANTIBODY JMK-E3

(Vicugna pacos) 		no annotation 6 VAL B   2
MET B  34
ARG B  72
VAL B  79
ALA B  98
TYR B 108
 None
 0.78A 3qxvD-5vxjB:
19.2		 3qxvD-5vxjB:
63.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5vxl SINGLE-DOMAIN
ANTIBODY JPS-G3

(Vicugna pacos) 		no annotation 5 ALA B  24
MET B  34
ARG B  73
ALA B  99
TYR B 106
 None
 0.69A 3qxvD-5vxlB:
20.2		 3qxvD-5vxlB:
66.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5vxl SINGLE-DOMAIN
ANTIBODY JPS-G3

(Vicugna pacos) 		no annotation 5 MET B  34
ARG B  73
VAL B  80
ALA B  99
TYR B 106
 None
 0.60A 3qxvD-5vxlB:
20.2		 3qxvD-5vxlB:
66.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wb1 ENVELOPE PROTEIN
US28, NANOBODY 7
FUSION PROTEIN

(Human
betaherpesvirus
5;
Lama glama) 		no annotation 6 VAL A1002
ALA A1024
MET A1034
VAL A1078
ALA A1097
TYR A1107
 None
 0.93A 3qxvD-5wb1A:
18.1		 3qxvD-5wb1A:
15.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5wb2 NANOBODY B1

(synthetic
construct) 		no annotation 5 ALA D  24
ARG D  72
VAL D  79
ALA D  98
TYR D 118
 None
 0.91A 3qxvD-5wb2D:
18.8		 3qxvD-5wb2D:
68.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5x0t 6H8 FAB FRAGMENT
HEAVY CHAIN

(Mus musculus) 		no annotation 5 ALA A  43
MET A  53
ARG A  93
VAL A 100
TYR A 124
 None
 0.76A 3qxvD-5x0tA:
19.7		 3qxvD-5x0tA:
31.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5x0t 6H8 FAB FRAGMENT
HEAVY CHAIN

(Mus musculus) 		no annotation 5 VAL A  21
MET A  53
ARG A  93
VAL A 100
TYR A 124
 None
 0.73A 3qxvD-5x0tA:
19.7		 3qxvD-5x0tA:
31.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5y9f HEAVY CHAIN OF FAB
FRAGMENT OF ANTIBODY
28F10

(Mus musculus) 		no annotation 5 VAL L   2
ALA L  24
MET L  34
ARG L  72
TYR L 112
 None
 0.96A 3qxvD-5y9fL:
20.0		 3qxvD-5y9fL:
57.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6dbe NANOBODY VHH R303

(Lama glama) 		no annotation 6 SER A  30
MET A  34
ARG A  72
VAL A  79
ALA A  98
TYR A 107
 None
 1.22A 3qxvD-6dbeA:
20.4		 3qxvD-6dbeA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6dbe NANOBODY VHH R303

(Lama glama) 		no annotation 6 VAL A   2
ALA A  24
MET A  34
VAL A  79
ALA A  98
TYR A 107
 None
 0.77A 3qxvD-6dbeA:
20.4		 3qxvD-6dbeA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6dbe NANOBODY VHH R303

(Lama glama) 		no annotation 6 VAL A   2
SER A  30
MET A  34
VAL A  79
ALA A  98
TYR A 107
 None
 1.03A 3qxvD-6dbeA:
20.4		 3qxvD-6dbeA:
undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6ehg HC3NB1

(Lama glama) 		no annotation 5 ALA C  24
MET C  34
ARG C  72
VAL C  79
ALA C  98
 None
 0.71A 3qxvD-6ehgC:
22.4		 3qxvD-6ehgC:
57.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6ehg HC3NB1

(Lama glama) 		no annotation 5 MET C  34
ARG C  72
VAL C  79
ALA C  98
TYR C 112
 None
 0.61A 3qxvD-6ehgC:
22.4		 3qxvD-6ehgC:
57.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6ehg HC3NB1

(Lama glama) 		no annotation 5 VAL C   2
ALA C  24
MET C  34
ARG C  72
VAL C  79
 None
 0.91A 3qxvD-6ehgC:
22.4		 3qxvD-6ehgC:
57.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6ehg HC3NB1

(Lama glama) 		no annotation 5 VAL C   2
MET C  34
ARG C  72
VAL C  79
TYR C 112
 None
 0.92A 3qxvD-6ehgC:
22.4		 3qxvD-6ehgC:
57.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6ey0 LLAMA NANOBODY NB01

(Lama glama) 		no annotation 5 MET E  34
ARG E  71
VAL E  78
ALA E  94
TYR E 102
 None
 0.87A 3qxvD-6ey0E:
21.3		 3qxvD-6ey0E:
56.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6gzp NANOBODY

(Lama glama) 		no annotation 6 VAL A   2
ALA A  24
MET A  34
ARG A  71
ALA A  94
TYR A 102
 None
 0.79A 3qxvD-6gzpA:
22.1		 3qxvD-6gzpA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1am2 MXE GYRA INTEIN

(Mycobacterium
xenopi) 		no annotation 3 LEU A  89
ARG A 107
ASN A  43
 None
 0.70A 3qxvD-1am2A:
undetectable		 3qxvD-1am2A:
21.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1cu1 PROTEIN
(PROTEASE/HELICASE
NS3)

(Hepacivirus C) 		PF02907
(Peptidase_S29)
PF07652
(Flavi_DEAD) 		3 LEU A 144
ARG A  92
ASN A  49
 None
 0.77A 3qxvD-1cu1A:
undetectable		 3qxvD-1cu1A:
11.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1e3h GUANOSINE
PENTAPHOSPHATE
SYNTHETASE

(Streptomyces
antibioticus) 		PF00013
(KH_1)
PF01138
(RNase_PH)
PF03726
(PNPase) 		3 LEU A 474
ARG A 433
ASN A 403
 None
 0.62A 3qxvD-1e3hA:
undetectable		 3qxvD-1e3hA:
10.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fng PROTEIN (MHC CLASS
II I-EK, BETA CHAIN)

(Mus musculus) 		PF00969
(MHC_II_beta)
PF07654
(C1-set) 		3 LEU B  38
ARG B  72
ASN B   5
 None
 0.62A 3qxvD-1fngB:
5.8		 3qxvD-1fngB:
22.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gaj HIGH-AFFINITY
BRANCHED CHAIN AMINO
ACID TRANSPORT
ATP-BINDING PROTEIN

(Methanocaldococcus
jannaschii) 		PF00005
(ABC_tran) 		3 LEU A   8
ARG A  86
ASN A  73
 None
PEG  A 600 ( 4.6A)
None
 0.73A 3qxvD-1gajA:
undetectable		 3qxvD-1gajA:
15.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1h0h FORMATE
DEHYDROGENASE
SUBUNIT ALPHA

(Desulfovibrio
gigas) 		PF00384
(Molybdopterin)
PF01568
(Molydop_binding)
PF04879
(Molybdop_Fe4S4) 		3 LEU A 391
ARG A 172
ASN A 404
 None
 0.58A 3qxvD-1h0hA:
undetectable		 3qxvD-1h0hA:
9.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1h3g CYCLOMALTODEXTRINASE

(Flavobacterium
sp. 92) 		PF00128
(Alpha-amylase)
PF09087
(Cyc-maltodext_N)
PF10438
(Cyc-maltodext_C) 		3 LEU A 398
ARG A 508
ASN A 436
 None
 0.72A 3qxvD-1h3gA:
3.5		 3qxvD-1h3gA:
12.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1i2o TRANSALDOLASE B

(Escherichia
coli) 		PF00923
(TAL_FSA) 		3 LEU A  83
ARG A 114
ASN A 126
 None
 0.76A 3qxvD-1i2oA:
undetectable		 3qxvD-1i2oA:
17.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nrk YGFZ PROTEIN

(Escherichia
coli) 		PF01571
(GCV_T) 		3 LEU A 162
ARG A  91
ASN A  72
 SO4  A 400 (-4.3A)
None
None
 0.76A 3qxvD-1nrkA:
undetectable		 3qxvD-1nrkA:
16.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nvt SHIKIMATE
5'-DEHYDROGENASE

(Methanocaldococcus
jannaschii) 		PF01488
(Shikimate_DH)
PF08501
(Shikimate_dh_N) 		3 LEU A 229
ARG A 116
ASN A 109
 NAP  A 288 (-4.4A)
None
None
 0.75A 3qxvD-1nvtA:
undetectable		 3qxvD-1nvtA:
15.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ohf NUDAURELIA CAPENSIS
OMEGA VIRUS CAPSID
PROTEIN

(Nudaurelia
capensis omega
virus) 		PF03566
(Peptidase_A21) 		3 LEU A 393
ARG A 409
ASN A 364
 None
 0.62A 3qxvD-1ohfA:
2.3		 3qxvD-1ohfA:
11.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1r8w GLYCEROL DEHYDRATASE

(Clostridium
butyricum) 		PF01228
(Gly_radical)
PF02901
(PFL-like) 		3 LEU A 745
ARG A 673
ASN A 737
 None
 0.74A 3qxvD-1r8wA:
undetectable		 3qxvD-1r8wA:
10.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1sgj CITRATE LYASE, BETA
SUBUNIT

(Deinococcus
radiodurans) 		PF03328
(HpcH_HpaI) 		3 LEU A  25
ARG A  74
ASN A  17
 None
OAA  A 285 ( 2.3A)
None
 0.71A 3qxvD-1sgjA:
undetectable		 3qxvD-1sgjA:
15.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1woi AGMATINASE

(Deinococcus
radiodurans) 		PF00491
(Arginase) 		3 LEU A 181
ARG A 164
ASN A 159
 None
 0.67A 3qxvD-1woiA:
undetectable		 3qxvD-1woiA:
19.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xx4 3,2-TRANS-ENOYL-COA
ISOMERASE,
MITOCHONDRIAL

(Rattus
norvegicus) 		PF00378
(ECH_1) 		3 LEU A  95
ARG A 257
ASN A 179
 None
 0.76A 3qxvD-1xx4A:
undetectable		 3qxvD-1xx4A:
20.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ayi AMINOPEPTIDASE T

(Thermus
thermophilus) 		PF02073
(Peptidase_M29) 		3 LEU A 219
ARG A 286
ASN A 371
 None
 0.64A 3qxvD-2ayiA:
undetectable		 3qxvD-2ayiA:
14.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2iya OLEANDOMYCIN
GLYCOSYLTRANSFERASE

(Streptomyces
antibioticus) 		PF00201
(UDPGT) 		3 LEU A 259
ARG A 293
ASN A  27
 None
None
UDP  A1424 (-4.0A)
 0.71A 3qxvD-2iyaA:
undetectable		 3qxvD-2iyaA:
13.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2or7 T-CELL
IMMUNOGLOBULIN AND
MUCIN
DOMAIN-CONTAINING
PROTEIN 2

(Mus musculus) 		PF07686
(V-set) 		3 LEU A  17
ARG A  45
ASN A  60
 None
 0.78A 3qxvD-2or7A:
9.5		 3qxvD-2or7A:
21.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p57 GTPASE-ACTIVATING
PROTEIN ZNF289

(Homo sapiens) 		PF01412
(ArfGap) 		3 LEU A  45
ARG A 115
ASN A 103
 None
 0.66A 3qxvD-2p57A:
undetectable		 3qxvD-2p57A:
20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2q2r GLUCOKINASE 1,
PUTATIVE

(Trypanosoma
cruzi) 		PF02685
(Glucokinase) 		3 LEU A 107
ARG A  54
ASN A 355
 None
 0.56A 3qxvD-2q2rA:
undetectable		 3qxvD-2q2rA:
14.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qa1 POLYKETIDE OXYGENASE
PGAE

(Streptomyces
sp. PGA64) 		PF01494
(FAD_binding_3) 		3 LEU A  60
ARG A 390
ASN A 289
 None
None
FAD  A 500 (-3.5A)
 0.57A 3qxvD-2qa1A:
undetectable		 3qxvD-2qa1A:
14.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qa2 POLYKETIDE OXYGENASE
CABE

(Streptomyces) 		PF01494
(FAD_binding_3) 		3 LEU A  60
ARG A 390
ASN A 289
 None
None
FAD  A 500 (-3.6A)
 0.58A 3qxvD-2qa2A:
undetectable		 3qxvD-2qa2A:
15.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qqu BETA-FRUCTOFURANOSID
ASE

(Arabidopsis
thaliana) 		PF00251
(Glyco_hydro_32N)
PF08244
(Glyco_hydro_32C) 		3 LEU A 515
ARG A 480
ASN A 529
 None
 0.76A 3qxvD-2qquA:
undetectable		 3qxvD-2qquA:
15.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2r3v MEVALONATE KINASE

(Homo sapiens) 		PF00288
(GHMP_kinases_N)
PF08544
(GHMP_kinases_C) 		3 LEU A   7
ARG A 388
ASN A  34
 None
 0.68A 3qxvD-2r3vA:
undetectable		 3qxvD-2r3vA:
16.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ywk PUTATIVE RNA-BINDING
PROTEIN 11

(Homo sapiens) 		PF00076
(RRM_1) 		3 LEU A  26
ARG A  78
ASN A  71
 None
 0.71A 3qxvD-2ywkA:
undetectable		 3qxvD-2ywkA:
22.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yxx DIAMINOPIMELATE
DECARBOXYLASE

(Thermotoga
maritima) 		PF00278
(Orn_DAP_Arg_deC)
PF02784
(Orn_Arg_deC_N) 		3 LEU A 260
ARG A 285
ASN A 349
 None
 0.75A 3qxvD-2yxxA:
undetectable		 3qxvD-2yxxA:
17.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yyl 4-HYDROXYPHENYLACETA
TE-3-HYDROXYLASE

(Thermus
thermophilus) 		PF03241
(HpaB)
PF11794
(HpaB_N) 		3 LEU A 452
ARG A 338
ASN A 282
 None
 0.69A 3qxvD-2yylA:
undetectable		 3qxvD-2yylA:
13.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ayx MEMBRANE-BOUND
HYDROGENASE LARGE
SUBUNIT
MEMBRANE-BOUND
HYDROGENASE SMALL
SUBUNIT

(Hydrogenovibrio
marinus) 		PF00374
(NiFeSe_Hases)
PF01058
(Oxidored_q6)
PF14720
(NiFe_hyd_SSU_C) 		3 LEU A 265
ARG B 243
ASN A 255
 None
 0.77A 3qxvD-3ayxA:
undetectable		 3qxvD-3ayxA:
12.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bc8 O-PHOSPHOSERYL-TRNA(
SEC) SELENIUM
TRANSFERASE

(Mus musculus) 		PF05889
(SepSecS) 		3 LEU A 320
ARG A  86
ASN A  64
 EDO  A 502 (-3.9A)
None
None
 0.68A 3qxvD-3bc8A:
undetectable		 3qxvD-3bc8A:
15.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bc8 O-PHOSPHOSERYL-TRNA(
SEC) SELENIUM
TRANSFERASE

(Mus musculus) 		PF05889
(SepSecS) 		3 LEU A 408
ARG A 362
ASN A 435
 None
 0.69A 3qxvD-3bc8A:
undetectable		 3qxvD-3bc8A:
15.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3btp SINGLE-STRAND
DNA-BINDING PROTEIN

(Agrobacterium
fabrum) 		PF07229
(VirE2) 		3 LEU A 264
ARG A 113
ASN A 135
 None
 0.72A 3qxvD-3btpA:
undetectable		 3qxvD-3btpA:
12.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3but UNCHARACTERIZED
PROTEIN AF_0446

(Archaeoglobus
fulgidus) 		PF03168
(LEA_2) 		3 LEU A  73
ARG A 116
ASN A  44
 None
 0.76A 3qxvD-3butA:
undetectable		 3qxvD-3butA:
21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3cux MALATE SYNTHASE

(Bacillus
anthracis) 		PF01274
(Malate_synthase) 		3 LEU A 160
ARG A  97
ASN A 119
 None
 0.78A 3qxvD-3cuxA:
undetectable		 3qxvD-3cuxA:
12.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3d3a BETA-GALACTOSIDASE

(Bacteroides
thetaiotaomicron) 		PF01301
(Glyco_hydro_35) 		3 LEU A 156
ARG A 142
ASN A  81
 None
 0.73A 3qxvD-3d3aA:
2.8		 3qxvD-3d3aA:
12.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dez OROTATE
PHOSPHORIBOSYLTRANSF
ERASE

(Streptococcus
mutans) 		PF00156
(Pribosyltran) 		3 LEU A 194
ARG A   9
ASN A 175
 None
 0.64A 3qxvD-3dezA:
undetectable		 3qxvD-3dezA:
19.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ec1 YQEH GTPASE

(Geobacillus
stearothermophilus) 		PF01926
(MMR_HSR1) 		3 LEU A 267
ARG A 365
ASN A 346
 None
 0.75A 3qxvD-3ec1A:
undetectable		 3qxvD-3ec1A:
14.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ec1 YQEH GTPASE

(Geobacillus
stearothermophilus) 		PF01926
(MMR_HSR1) 		3 LEU A 352
ARG A 365
ASN A 346
 None
 0.78A 3qxvD-3ec1A:
undetectable		 3qxvD-3ec1A:
14.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3eh2 PROTEIN TRANSPORT
PROTEIN SEC24C

(Homo sapiens) 		PF00626
(Gelsolin)
PF04810
(zf-Sec23_Sec24)
PF04811
(Sec23_trunk)
PF04815
(Sec23_helical)
PF08033
(Sec23_BS) 		3 LEU A 660
ARG A 605
ASN A 522
 None
 0.66A 3qxvD-3eh2A:
1.3		 3qxvD-3eh2A:
11.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3emv URIDINE
PHOSPHORYLASE,
PUTATIVE

(Plasmodium
vivax) 		PF01048
(PNP_UDP_1) 		3 LEU A  35
ARG A 226
ASN A 221
 None
 0.66A 3qxvD-3emvA:
undetectable		 3qxvD-3emvA:
17.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fy4 6-4 PHOTOLYASE

(Arabidopsis
thaliana) 		PF00875
(DNA_photolyase)
PF03441
(FAD_binding_7) 		3 LEU A 226
ARG A 272
ASN A 280
 None
 0.70A 3qxvD-3fy4A:
undetectable		 3qxvD-3fy4A:
14.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gf8 PUTATIVE
POLYSACCHARIDE
BINDING PROTEINS
(DUF1812)

(Bacteroides
thetaiotaomicron) 		PF08842
(Mfa2) 		3 LEU A 266
ARG A 168
ASN A 199
 None
 0.46A 3qxvD-3gf8A:
2.3		 3qxvD-3gf8A:
18.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gse MENAQUINONE-SPECIFIC
ISOCHORISMATE
SYNTHASE

(Yersinia pestis) 		PF00425
(Chorismate_bind) 		3 LEU A 331
ARG A 259
ASN A 303
 None
SO4  A 456 (-3.0A)
None
 0.75A 3qxvD-3gseA:
undetectable		 3qxvD-3gseA:
13.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3h0g DNA-DIRECTED RNA
POLYMERASE II
SUBUNIT RPB1
DNA-DIRECTED RNA
POLYMERASE II
SUBUNIT RPB2

(Schizosaccharomyces
pombe) 		PF00562
(RNA_pol_Rpb2_6)
PF00623
(RNA_pol_Rpb1_2)
PF04560
(RNA_pol_Rpb2_7)
PF04561
(RNA_pol_Rpb2_2)
PF04563
(RNA_pol_Rpb2_1)
PF04565
(RNA_pol_Rpb2_3)
PF04566
(RNA_pol_Rpb2_4)
PF04567
(RNA_pol_Rpb2_5)
PF04983
(RNA_pol_Rpb1_3)
PF04990
(RNA_pol_Rpb1_7)
PF04992
(RNA_pol_Rpb1_6)
PF04997
(RNA_pol_Rpb1_1)
PF04998
(RNA_pol_Rpb1_5)
PF05000
(RNA_pol_Rpb1_4) 		3 LEU B1140
ARG A 845
ASN A 451
 None
 0.75A 3qxvD-3h0gB:
undetectable		 3qxvD-3h0gB:
7.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hg7 D-ISOMER SPECIFIC
2-HYDROXYACID
DEHYDROGENASE FAMILY
PROTEIN

(Aeromonas
salmonicida) 		PF02826
(2-Hacid_dh_C) 		3 LEU A 262
ARG A 245
ASN A 236
 None
 0.66A 3qxvD-3hg7A:
undetectable		 3qxvD-3hg7A:
16.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jb9 SMALL NUCLEAR
RIBONUCLEOPROTEIN F
SMALL NUCLEAR
RIBONUCLEOPROTEIN SM
D2

(Schizosaccharomyces
pombe) 		PF01423
(LSM) 		3 LEU I  64
ARG G  48
ASN G  65
 None
U  C 103 ( 2.9A)
U  C 101 ( 3.2A)
 0.71A 3qxvD-3jb9I:
undetectable		 3qxvD-3jb9I:
21.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jxa CONTACTIN 4

(Mus musculus) 		PF07679
(I-set)
PF13927
(Ig_3) 		3 LEU A 214
ARG A 170
ASN A 252
 None
 0.58A 3qxvD-3jxaA:
7.8		 3qxvD-3jxaA:
18.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3l4k DNA TOPOISOMERASE 2

(Saccharomyces
cerevisiae) 		PF00521
(DNA_topoisoIV)
PF01751
(Toprim)
PF16898
(TOPRIM_C) 		3 LEU A 790
ARG A 854
ASN A 845
 None
 0.64A 3qxvD-3l4kA:
undetectable		 3qxvD-3l4kA:
11.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lm3 UNCHARACTERIZED
PROTEIN

(Parabacteroides
distasonis) 		PF12979
(DUF3863)
PF12980
(DUF3864) 		3 LEU A 399
ARG A 469
ASN A 392
 None
 0.66A 3qxvD-3lm3A:
undetectable		 3qxvD-3lm3A:
13.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lpp SUCRASE-ISOMALTASE

(Homo sapiens) 		PF00088
(Trefoil)
PF01055
(Glyco_hydro_31)
PF16863
(NtCtMGAM_N) 		3 LEU A 888
ARG A 858
ASN A 863
 None
 0.56A 3qxvD-3lppA:
undetectable		 3qxvD-3lppA:
9.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mru AMINOACYL-HISTIDINE
DIPEPTIDASE

(Vibrio
alginolyticus) 		PF01546
(Peptidase_M20)
PF07687
(M20_dimer) 		3 LEU A 383
ARG A 369
ASN A 230
 None
 0.73A 3qxvD-3mruA:
undetectable		 3qxvD-3mruA:
12.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mw6 UNCHARACTERIZED
PROTEIN NMB1681

(Neisseria
meningitidis) 		PF04352
(ProQ) 		3 LEU A  52
ARG A  87
ASN A  92
 None
 0.69A 3qxvD-3mw6A:
undetectable		 3qxvD-3mw6A:
19.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3oc5 TOXIN COREGULATED
PILUS BIOSYNTHESIS
PROTEIN F

(Vibrio cholerae) 		PF06340
(TcpF) 		3 LEU A 297
ARG A 112
ASN A 145
 None
 0.74A 3qxvD-3oc5A:
3.4		 3qxvD-3oc5A:
18.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pt5 NANS (YJHS), A
9-O-ACETYL
N-ACETYLNEURAMINIC
ACID ESTERASE

(Escherichia
coli) 		PF03629
(SASA) 		3 LEU A 173
ARG A  40
ASN A 167
 None
 0.78A 3qxvD-3pt5A:
undetectable		 3qxvD-3pt5A:
16.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3s5k FALCILYSIN

(Plasmodium
falciparum) 		PF00675
(Peptidase_M16)
PF05193
(Peptidase_M16_C)
PF08367
(M16C_assoc) 		3 LEU A 912
ARG A 854
ASN A 894
 None
 0.72A 3qxvD-3s5kA:
undetectable		 3qxvD-3s5kA:
6.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3sun DNA POLYMERASE

(Escherichia
virus RB69) 		PF00136
(DNA_pol_B)
PF03104
(DNA_pol_B_exo1) 		3 LEU A 373
ARG A 384
ASN A 582
 None
 0.77A 3qxvD-3sunA:
undetectable		 3qxvD-3sunA:
9.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ubd RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus musculus) 		PF00069
(Pkinase) 		3 LEU A 145
ARG A 110
ASN A 198
 SL0  A 400 ( 4.8A)
None
None
 0.75A 3qxvD-3ubdA:
undetectable		 3qxvD-3ubdA:
17.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wpe TOLL-LIKE RECEPTOR 9

(Bos taurus) 		PF13516
(LRR_6)
PF13855
(LRR_8) 		3 LEU A 598
ARG A 657
ASN A 606
 None
 0.73A 3qxvD-3wpeA:
undetectable		 3qxvD-3wpeA:
8.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4b67 L-ORNITHINE N5
MONOOXYGENASE

(Aspergillus
fumigatus) 		PF13434
(K_oxygenase) 		3 LEU A 471
ARG A 144
ASN A 323
 None
FAD  A1492 ( 3.8A)
NAP  A1493 ( 2.9A)
 0.64A 3qxvD-4b67A:
undetectable		 3qxvD-4b67A:
14.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4blf SINGLE-STRAND
DNA-BINDING PROTEIN

(Agrobacterium
tumefaciens) 		PF07229
(VirE2) 		3 LEU A 264
ARG A 113
ASN A 135
 None
 0.74A 3qxvD-4blfA:
undetectable		 3qxvD-4blfA:
21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4cu9 BETA-GALACTOSIDASE

(Streptococcus
pneumoniae) 		no annotation 3 LEU A1896
ARG A1976
ASN A1863
 None
 0.72A 3qxvD-4cu9A:
2.2		 3qxvD-4cu9A:
24.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4e5v PUTATIVE THUA-LIKE
PROTEIN

(Parabacteroides
merdae) 		PF06283
(ThuA) 		3 LEU A 231
ARG A 202
ASN A 120
 None
None
EDO  A 403 (-3.3A)
 0.78A 3qxvD-4e5vA:
undetectable		 3qxvD-4e5vA:
17.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fzw 2,3-DEHYDROADIPYL-CO
A HYDRATASE

(Escherichia
coli) 		PF00378
(ECH_1) 		3 LEU A  15
ARG A  87
ASN A  92
 None
 0.58A 3qxvD-4fzwA:
undetectable		 3qxvD-4fzwA:
18.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gyp GLUCARATE
DEHYDRATASE-RELATED
PROTEIN

(Escherichia
coli) 		PF02746
(MR_MLE_N)
PF13378
(MR_MLE_C) 		3 LEU C 127
ARG C  78
ASN C  45
 None
 0.76A 3qxvD-4gypC:
undetectable		 3qxvD-4gypC:
14.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4h5y LIDA PROTEIN,
SUBSTRATE OF THE
DOT/ICM SYSTEM

(Legionella
pneumophila) 		no annotation 3 LEU A  93
ARG A 141
ASN A 124
 None
 0.73A 3qxvD-4h5yA:
undetectable		 3qxvD-4h5yA:
12.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4i6f SERINE/THREONINE-PRO
TEIN KINASE PLK2

(Homo sapiens) 		PF00069
(Pkinase) 		3 LEU A 137
ARG A 204
ASN A 210
 None
 0.78A 3qxvD-4i6fA:
undetectable		 3qxvD-4i6fA:
20.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4iv9 TRYPTOPHAN
2-MONOOXYGENASE

(Pseudomonas
savastanoi) 		PF01593
(Amino_oxidase) 		3 LEU A 167
ARG A 202
ASN A 208
 None
 0.73A 3qxvD-4iv9A:
undetectable		 3qxvD-4iv9A:
15.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kjv E3 UBIQUITIN-PROTEIN
LIGASE XIAP

(Homo sapiens) 		PF00653
(BIR) 		3 LEU A 189
ARG A 222
ASN A 226
 None
1RK  A 502 (-4.2A)
None
 0.67A 3qxvD-4kjvA:
undetectable		 3qxvD-4kjvA:
18.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mzy NICOTINATE
PHOSPHORIBOSYLTRANSF
ERASE

(Enterococcus
faecalis) 		PF04095
(NAPRTase) 		3 LEU A 447
ARG A 147
ASN A 110
 None
None
GOL  A 513 ( 4.0A)
 0.68A 3qxvD-4mzyA:
undetectable		 3qxvD-4mzyA:
13.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4n9x PUTATIVE
MONOOXYGENASE

(Pectobacterium
atrosepticum) 		PF01494
(FAD_binding_3) 		3 LEU A 117
ARG A  62
ASN A 303
 None
 0.70A 3qxvD-4n9xA:
undetectable		 3qxvD-4n9xA:
13.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qxl FLAGELLAR PROTEIN
FLHE

(Salmonella
enterica) 		PF06366
(FlhE) 		3 LEU A  58
ARG A  30
ASN A 112
 None
 0.65A 3qxvD-4qxlA:
undetectable		 3qxvD-4qxlA:
23.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ri6 PHI CLASS
GLUTATHIONE
TRANSFERASE GSTF1

(Populus tremula
x Populus
tremuloides) 		PF00043
(GST_C)
PF02798
(GST_N) 		3 LEU A 170
ARG A 155
ASN A 193
 None
 0.48A 3qxvD-4ri6A:
undetectable		 3qxvD-4ri6A:
21.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rqo L-SERINE DEHYDRATASE

(Legionella
pneumophila) 		PF03313
(SDH_alpha)
PF03315
(SDH_beta) 		3 LEU A 236
ARG A 399
ASN A 279
 None
SF4  A 500 ( 4.6A)
None
 0.65A 3qxvD-4rqoA:
undetectable		 3qxvD-4rqoA:
16.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4u63 DNA PHOTOLYASE

(Agrobacterium
fabrum) 		PF00875
(DNA_photolyase)
PF03441
(FAD_binding_7) 		3 LEU A  59
ARG A 101
ASN A  21
 None
 0.63A 3qxvD-4u63A:
undetectable		 3qxvD-4u63A:
13.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wz9 AGAP004809-PA

(Anopheles
gambiae) 		PF01433
(Peptidase_M1)
PF11838
(ERAP1_C) 		3 LEU A 193
ARG A 341
ASN A 334
 None
 0.65A 3qxvD-4wz9A:
undetectable		 3qxvD-4wz9A:
9.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4x4j PUTATIVE OXYGENASE

(Amycolatopsis
orientalis) 		PF01494
(FAD_binding_3) 		3 LEU A  60
ARG A 390
ASN A 289
 None
None
FAD  A 503 (-3.4A)
 0.71A 3qxvD-4x4jA:
undetectable		 3qxvD-4x4jA:
12.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xgc ORIGIN RECOGNITION
COMPLEX SUBUNIT 1

(Drosophila
melanogaster) 		PF00004
(AAA)
PF09079
(Cdc6_C) 		3 LEU A 905
ARG A 692
ASN A 718
 None
 0.60A 3qxvD-4xgcA:
undetectable		 3qxvD-4xgcA:
15.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yfa PROTEIN RELATED TO
PENICILLIN ACYLASE

(Acidovorax sp.
MR-S7) 		PF01804
(Penicil_amidase) 		3 LEU A  72
ARG A  91
ASN A 174
 None
 0.77A 3qxvD-4yfaA:
undetectable		 3qxvD-4yfaA:
23.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yfa PROTEIN RELATED TO
PENICILLIN ACYLASE

(Acidovorax sp.
MR-S7) 		PF01804
(Penicil_amidase) 		3 LEU A  78
ARG A  91
ASN A 174
 None
 0.68A 3qxvD-4yfaA:
undetectable		 3qxvD-4yfaA:
23.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zdl O-PHOSPHOSERYL-TRNA(
SEC) SELENIUM
TRANSFERASE

(Homo sapiens) 		PF05889
(SepSecS) 		3 LEU A 408
ARG A 362
ASN A 435
 None
 0.66A 3qxvD-4zdlA:
undetectable		 3qxvD-4zdlA:
13.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4zxb FAB 83-7 HEAVY CHAIN
INSULIN RECEPTOR

(Homo sapiens;
Mus musculus) 		PF00041
(fn3)
PF00757
(Furin-like)
PF01030
(Recep_L_domain)
PF07654
(C1-set)
PF07686
(V-set) 		3 LEU A   4
ARG E 236
ASN A  73
 None
 0.51A 3qxvD-4zxbA:
19.1		 3qxvD-4zxbA:
48.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5aar POTASSIUM CHANNEL
AKT1

(Arabidopsis
thaliana) 		PF12796
(Ank_2) 		3 LEU A 534
ARG A 552
ASN A 545
 None
 0.77A 3qxvD-5aarA:
undetectable		 3qxvD-5aarA:
19.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5aul PHOSPHATIDYLINOSITOL
3-KINASE REGULATORY
SUBUNIT ALPHA

(Homo sapiens) 		PF00017
(SH2) 		3 LEU A 710
ARG A 649
ASN A 673
 None
 0.78A 3qxvD-5aulA:
undetectable		 3qxvD-5aulA:
22.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5c9i PROTEIN RELATED TO
PENICILLIN ACYLASE

(Acidovorax sp.
MR-S7) 		PF01804
(Penicil_amidase) 		3 LEU A  72
ARG A  91
ASN A 174
 None
 0.77A 3qxvD-5c9iA:
undetectable		 3qxvD-5c9iA:
11.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5c9i PROTEIN RELATED TO
PENICILLIN ACYLASE

(Acidovorax sp.
MR-S7) 		PF01804
(Penicil_amidase) 		3 LEU A  78
ARG A  91
ASN A 174
 None
 0.66A 3qxvD-5c9iA:
undetectable		 3qxvD-5c9iA:
11.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5e4i CONTACTIN-5

(Mus musculus) 		PF07679
(I-set)
PF13927
(Ig_3) 		3 LEU A 288
ARG A 244
ASN A 326
 None
 0.74A 3qxvD-5e4iA:
8.1		 3qxvD-5e4iA:
16.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5evl BETA-LACTAMASE

(Chromobacterium
violaceum) 		PF00144
(Beta-lactamase) 		3 LEU A 364
ARG A 351
ASN A 314
 None
 0.78A 3qxvD-5evlA:
undetectable		 3qxvD-5evlA:
18.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5f7u CYCLOALTERNAN-FORMIN
G ENZYME

(Listeria
monocytogenes) 		PF01055
(Glyco_hydro_31)
PF13802
(Gal_mutarotas_2)
PF16338
(DUF4968)
PF16990
(CBM_35) 		3 LEU A 534
ARG A 614
ASN A 588
 None
GLC  A1116 (-2.8A)
None
 0.74A 3qxvD-5f7uA:
3.3		 3qxvD-5f7uA:
7.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jly THIOREDOXIN
PEROXIDASE-1

(Schistosoma
japonicum) 		PF00578
(AhpC-TSA)
PF10417
(1-cysPrx_C) 		3 LEU A  27
ARG A 136
ASN A  66
 None
 0.78A 3qxvD-5jlyA:
undetectable		 3qxvD-5jlyA:
18.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5kyu PROTEIN TRANSPORT
PROTEIN SEC24D

(Homo sapiens) 		PF00626
(Gelsolin)
PF04810
(zf-Sec23_Sec24)
PF04811
(Sec23_trunk)
PF04815
(Sec23_helical)
PF08033
(Sec23_BS) 		3 LEU B 926
ARG B 871
ASN B 788
 None
 0.73A 3qxvD-5kyuB:
1.8		 3qxvD-5kyuB:
9.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5mpd 26S PROTEASOME
REGULATORY SUBUNIT
RPN7

(Saccharomyces
cerevisiae) 		PF01399
(PCI)
PF10602
(RPN7) 		3 LEU R 154
ARG R 209
ASN R  23
 None
 0.73A 3qxvD-5mpdR:
undetectable		 3qxvD-5mpdR:
15.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5n1q METHYL-COENZYME M
REDUCTASE III FROM
METHANOTHERMOCOCCUS
THERMOLITHOTROPHICUS
SUBUNIT GAMMA

(Methanothermococcus
thermolithotrophicus) 		PF02240
(MCR_gamma) 		3 LEU C  31
ARG C 151
ASN C  17
 None
 0.77A 3qxvD-5n1qC:
undetectable		 3qxvD-5n1qC:
17.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5na7 PUTATIVE
DIPEPTIDYL-PEPTIDASE
III

(Bacteroides
thetaiotaomicron) 		no annotation 3 LEU A 157
ARG A  81
ASN A  90
 None
 0.68A 3qxvD-5na7A:
undetectable		 3qxvD-5na7A:
11.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5u56 MACROPHAGE GROWTH
LOCUS A
STRINGENT STARVATION
PROTEIN A

(Francisella
tularensis) 		PF00043
(GST_C)
PF13417
(GST_N_3) 		3 LEU C 150
ARG A  89
ASN C  63
 None
 0.76A 3qxvD-5u56C:
undetectable		 3qxvD-5u56C:
21.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5y3j TOLL-LIKE RECEPTOR 9

(Equus caballus) 		no annotation 3 LEU A 600
ARG A 659
ASN A 608
 None
 0.69A 3qxvD-5y3jA:
undetectable		 3qxvD-5y3jA:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6axf RAS GUANYL-RELEASING
PROTEIN 2

(Homo sapiens) 		no annotation 3 LEU A 361
ARG A 351
ASN A 239
 None
 0.77A 3qxvD-6axfA:
undetectable		 3qxvD-6axfA:
16.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6b23 MAJOR HEAD PROTEIN

(Staphylococcus
virus 80alpha) 		no annotation 3 LEU A  39
ARG A 104
ASN A 100
 None
 0.75A 3qxvD-6b23A:
undetectable		 3qxvD-6b23A:
15.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6dfu TRYPTOPHAN--TRNA
LIGASE

(Haemophilus
influenzae) 		no annotation 3 LEU A  64
ARG A 307
ASN A  75
 None
 0.77A 3qxvD-6dfuA:
undetectable		 3qxvD-6dfuA:
19.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6eon BETA-GALACTOSIDASE

(Bacteroides
thetaiotaomicron) 		no annotation 3 LEU A 156
ARG A 142
ASN A  81
 None
 0.72A 3qxvD-6eonA:
2.2		 3qxvD-6eonA:
10.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fuy VINCULIN

(Homo sapiens) 		no annotation 3 LEU A 609
ARG A 684
ASN A 229
 None
 0.62A 3qxvD-6fuyA:
undetectable		 3qxvD-6fuyA:
19.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6g96 ACETYLTRANSFERASE

(Salmonella
enterica) 		no annotation 3 LEU B 110
ARG B  57
ASN B  28
 None
 0.73A 3qxvD-6g96B:
undetectable		 3qxvD-6g96B:
19.38